Showing results (81-90 of 131) with videos related to
Sort By:
Pageof 14
Cancer Research|November 25, 2003
Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapyKoji Teramoto, Keiichi Kontani, Yoshitomo Ozaki, et al.American Journal of Respiratory and Critical Care Medicine|March 5, 2003
Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung diseaseHajime Fujimoto, Esteban Cesar Gabazza, Osamu Hataji, et al.Plos One|September 7, 2013
Differential gene expression in thrombomodulin (TM; CD141)(+) and TM(-) dendritic cell subsetsMasaaki Toda, Zhifei Shao, Ken D Yamaguchi, et al.Biochemical and Biophysical Research Communications|January 22, 2008
Role of thrombin in interleukin-5 expression from basophilsAiko Yamaguchi, Esteban C Gabazza, Yoshiyuki Takei, et al.Oncology Research|January 12, 2018
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung CancerAtsushi Fujiwara, Masamichi Yoshida, Hajime Fujimoto, et al.Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case ReportYoichi Nishii, Kazuki Furuhashi, Kentaro Ito, et al.BMJ (Clinical Research Ed.)|March 10, 2010
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trialTakaya Maruyama, Osamu Taguchi, Michael S Niederman, et al.Allergology International : Official Journal of the Japanese Society of Allergology|December 26, 2013
Thrombomodulin modulates dendritic cells via both antagonism of high mobility group protein B1 and an independent mechanismMasaaki Toda, Corina N D'Alessandro-Gabazza, Takehiro Takagi, et al.The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuriaYutaka Yano, Nagako Kitagawa, Esteban C Gabazza, et al.Pageof 14